ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Precision IFX: Using a Dashboard to Individualize Infliximab Dosage

Not Applicable

Completed

Conditions: Inflammatory Bowel Disease

Interventions: Other: Individualized Dosage Precision IFX Dashboard

First Posted Date: 2015-12-08

Last Posted Date: 2021-05-18

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 189

Registration Number: NCT02624037

Locations: 🇺🇸
Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, New York, New York, United States

A Study of Secukinumab for the Treatment of Alopecia Areata

Phase 2

Terminated

Conditions: Alopecia Areata

Interventions: Drug: Placebo
Drug: Secukinumab

First Posted Date: 2015-11-06

Last Posted Date: 2021-03-11

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 11

Registration Number: NCT02599129

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Secukinumab for Treatment of Atopic Dermatitis

Phase 2

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: Placebo
Drug: Secukinumab

First Posted Date: 2015-11-01

Last Posted Date: 2019-06-12

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 41

Registration Number: NCT02594098

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Targeting Platelets in Chronic HIV Infection

Phase 2

Completed

Conditions: HIV-1 Infection

Interventions: Drug: Placebo
Drug: Aspirin
Drug: Clopidogrel

First Posted Date: 2015-10-19

Last Posted Date: 2018-02-28

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 27

Registration Number: NCT02578706

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study

Phase 3

Completed

Conditions: Vascular Inflammation
Atherosclerotic Cardiovascular Disease

Interventions: Drug: Low dose methotrexate
Drug: Placebo

First Posted Date: 2015-10-15

Last Posted Date: 2020-04-20

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 123

Registration Number: NCT02576067

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Non Invasive Neuromonitoring After Cardiac Arrest

Completed

Conditions: Cardiac Arrest

Interventions: Device: Non-invasive cerebral flow monitoring

First Posted Date: 2015-10-14

Last Posted Date: 2017-04-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 21

Registration Number: NCT02575196

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps

Phase 2

Terminated

Conditions: Polyp of Nasal Sinus

Interventions: Drug: Doxycycline
Drug: Flonase
Drug: methylprednisolone
Drug: nasal saline spray
Drug: sugar pill

First Posted Date: 2015-10-06

Last Posted Date: 2018-01-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 49

Registration Number: NCT02569437

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Utility of Ultrasound Assessment of the Inferior Vena Cava in Patients With Sepsis and Dehydration

Not Applicable

Terminated

Conditions: Dehydration
Gastroenteritis
Sepsis

Interventions: Device: SonoSite Maxx Series Ultrasound System

First Posted Date: 2015-10-05

Last Posted Date: 2024-06-13

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 112

Registration Number: NCT02568189

Locations: 🇺🇸
Mount Sinai Hospital Department of Emergency Medicine, New York, New York, United States

Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Device: MyoVista device
Device: Computed tomographic coronary angiography
Device: Transthoracic Echocardiography

First Posted Date: 2015-09-25

Last Posted Date: 2017-10-23

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 200

Registration Number: NCT02560168

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Noom Monitor for Binge Eating

Not Applicable

Completed

Conditions: Binge Eating Disorder

Interventions: Behavioral: CBT-GSH with Noom Monitor

First Posted Date: 2015-09-21

Last Posted Date: 2019-09-27

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 225

Registration Number: NCT02555553

Locations: 🇺🇸
Kaiser Permanente Center for Health Research, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy